Navigation Links
Canada should significantly increase its funding of randomized clinical trials
Date:5/22/2012

Large randomized controlled trials (RCTs) are critical for determining effectiveness of medical therapies, tests and procedures. Yet Canada provides scant support for these studies compared with other western countries, states an analysis in CMAJ (Canadian Medical Association Journal).

Dr. Salim Yusuf, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, with Dr. John Cairns, University of British Columbia, argue in the analysis and appendix that Canada should provide better financial support of clinical trials and remove some of the bureaucratic and administrative barriers that are challenging to conducting trials in Canada.

It is critical to fund clinical trials in Canada, rather than relying on evidence from trials conducted in other countries. Countries that conduct RCTs are usually the first to experience the health benefits of the trials. As well, some studies must be conducted locally because of the unique social and health context. RCTs also provide economic stimulus and have led to successful industry spin offs.

Canada's major funding agency, the Canadian Institutes of Health Research (CIHR), provided about Can$1 billion in research funding in 2010/11, equivalent to Can$29 per capita or 0.07% of overall gross domestic product (GDP). This is significantly less than in the US, which provided Can$31 billion in 2010/11 US$100 per capita or 0.2% of the US GDP. The United Kingdom provides Can$3.2 billion, or Can$45 per capita expenditure, 0.12% of the UK GDP. In Canada and the US, provincial governments and health charities also provide additional funding.

The disparity between countries widens when one looks at specific funding for clinical trials. CIHR allocated only 3.3% of its budget (2009/10) to clinical trials, whereas the US National Institutes of Health spent 11% of its Can$31 billion total budget on clinical trials.

"The CIHR should sharply increase funding for peer review for clinical trials to more than 10% of its overall budget," write the authors. "This shift could happen within the next four to five years and grow to 15% of the total CIHR budget to ensure that the clinical relevance of discoveries from other forms of research can be rapidly assessed."

"Developing, enhancing and sustaining Canada's capacity to conduct world-class clinical studies will enable Canada to make important contributions that will improve health," the authors conclude.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Related medicine news :

1. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
2. DTM Systems Corporation Ranked Number One as the Largest Reseller in British Columbia to Hewlett Packard Canada
3. Strategic Connections Ranks 90th Fastest-Growing Technology Company in North America and 14th in Canada
4. Canadian EMR Vendor Nightingale Exhibiting at Spring 2010 Canada Health Infoway Partnership Conference
5. Tax Return Appointment Fees to be Donated to Charity by Tax Team Canada
6. Canada joins international network providing free access to health research
7. AMD Global Telemedicine Inc. Chosen by InterHealth Canada as the Telemedicine Solutions Provider for Turks and Caicos Hospital Project
8. 'Winds of Change with Jivi' Breathes New Life to Daytime Talk Show Landscape in Canada
9. Muscle Building Expert Vince Del Monte Feeds the Hungry with a $5,000 Donation to the Hamilton Food Share in Canada
10. Survey highlights major Canada-US differences in people in middle age
11. Summertime Decadence: Rodelle Cocoa Launches in Western Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: